http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106432039-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-452 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-452 |
filingDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106432039-B |
titleOfInvention | 3,4- diaryl maleimide derivatives and the preparation method and application thereof |
abstract | The invention discloses a kind of 3,4- diaryl maleimide derivatives and its acceptable salt indicated by general formula I.The invention also discloses the preparation method of 3,4- diaryl maleimide derivatives above-mentioned and its applications in the drug that preparation prevention or treatment atherosclerosis and preparation reduce blood plasma cholesterol level.Compared with prior art, present invention could apply to treat or prevent atherosclerosis or reduce blood plasma cholesterol level, reduction plasma cholesterol activity is stronger, and market prospects are broader. |
priorityDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.